Barely Significant
← all excerpts

The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease.

Clin Ophthalmol · 2007 · PMC2701133 · PMID 19668474

Europe PMC
1
hedged sentence
0.0430
closest p · 0.9× alpha
0.0430
boldest claim

The sentences

barely significantp = 0.043actually significant
The OI reduced by −1.12 in the LAR group (p = 0.0017) versus −0.23 with placebo (p = 0.33), giving a barely significant treatment effect by Wilcoxon’s rank sum test (p = 0.043), but analysis of covariance failed to confirm this (p = 0.16).

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.